Welcome to our dedicated page for BrightSpring Health Services SEC filings (Ticker: BTSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Pharmacy reimbursement shifts, multi-state Medicaid rules, and hospice occupancy metrics all live inside BrightSpring Health Services’ dense disclosures. If you’ve ever opened the annual report searching for segment profit only to meet 300 pages of jargon, you know the challenge. BrightSpring’s integrated pharmacy and provider model produces footnote-heavy numbers tying drug dispensing to home health visits—hard to trace in a hurry. Stock Titan surfaces what matters, turning complex paragraphs into clear sentences—BrightSpring Health Services SEC filings explained simply.
Whether you need the BrightSpring Health Services quarterly earnings report 10-Q filing or want BrightSpring Health Services insider trading Form 4 transactions, every document appears here the moment EDGAR posts. Our AI parses each form and delivers:
- Instant red-flag summaries for BrightSpring Health Services 8-K material events explained
- Segment revenue trends from the BrightSpring Health Services earnings report filing analysis
- Real-time alerts for BrightSpring Health Services Form 4 insider transactions real-time, including option grants and dispositions
- A straightforward view of the BrightSpring Health Services proxy statement executive compensation
Ask naturally—“How do I read the BrightSpring Health Services annual report 10-K simplified?” or “Where can I track BrightSpring Health Services executive stock transactions Form 4?”—and our engine delivers. From understanding BrightSpring Health Services SEC documents with AI to comparing pharmacy margins quarter over quarter, you get complete coverage, real-time filing updates, and AI-powered context that helps professionals evaluate risk, model cash flows, and monitor compliance with confidence.
BrightSpring Health Services, Inc. is registering the resale of 15,000,000 shares of common stock by selling stockholders under a prospectus supplement filed pursuant to Rule 424(b)(7). The company will not receive proceeds from these sales, other than cash received from management stockholders’ option exercises made in connection with the offering.
The underwriter agreed to purchase at
BTSG is listed on Nasdaq; the shares closed at
Preliminary Q3 2025 results (continuing ops): revenue
BrightSpring Health Services filed a resale prospectus for 15,000,000 shares of common stock offered by selling stockholders. The company will not receive proceeds from these sales, other than cash from option exercises by management selling stockholders.
Subject to completion of the offering, BrightSpring intends a concurrent stock repurchase of up to the lesser of $50 million or 10% of the offering, with repurchased shares to be cancelled. Shares outstanding were 181,045,317 as of October 17, 2025. Following the offering and the repurchase, shares outstanding would be 179,800,317 assuming a repurchase price of $29.73 and issuance of 255,000 option shares.
Preliminary Q3 2025 results show total revenue of $3,334 million (up 28.2% year over year), gross profit of $392 million (up 21.3%), net income of $37.5 million (vs. a $25.7 million loss), and Adjusted EBITDA $160 million (up 37.2%). As of September 30, 2025, cash and cash equivalents were $140.3 million, total debt was approximately $2.6 billion, and leverage under credit agreements was 3.31x.
BrightSpring Health Services furnished an 8-K announcing it issued a press release with certain preliminary financial information for the third quarter ended September 30, 2025. The press release is provided as Exhibit 99.1.
The disclosure under Item 2.02 is expressly treated as furnished, not filed, under the Exchange Act. The filing also lists Exhibit 104 for the cover page Inline XBRL data.
BrightSpring Health Services (BTSG) reported a Form 144 notice declaring a proposed sale of 16,168 common shares through Fidelity Brokerage Services on NASDAQ with an aggregate market value of $362,240.87, scheduled approximately for 08/14/2025. The filing shows the shares arose from two acquisitions: 9,945 shares from restricted stock vesting on 01/25/2025 (compensation) and 6,223 shares from an option exercise dated 08/14/2025 (cash). The filer reports 177,148,693 shares outstanding and notes no sales by the filer in the past three months.
The Vanguard Group filed a Schedule 13G reporting a passive position in BrightSpring Health Services Inc. (BTSG) as of 30 June 2025.
- Beneficial ownership: 9,027,797 common shares, or 5.13 % of outstanding stock.
- Voting power: 0 sole and 98,078 shared votes, underscoring a non-activist stance.
- Dispositive power: 8,860,569 sole and 167,228 shared shares.
- Filed under Rule 13d-1(b) with investment-adviser (IA) status, indicating ordinary-course asset-management ownership.
- Certification confirms no intent to change or influence BTSG control.
The filing positions Vanguard as a ≥5 % holder, broadening BTSG’s institutional base while carrying limited governance influence.
FAQ
What is the current stock price of BrightSpring Health Services (BTSG)?
What is the market cap of BrightSpring Health Services (BTSG)?
